Holdings
Checkpoint Capital L.P.
As of Sep 30, 2026, Checkpoint Capital L.P. reported 7 positions worth US$441M. Largest: argenx SE, Rhythm Pharmaceuticals, Inc. and Revolution Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| argenx SE | 182K | US$174M | +50,217 | Sep 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 1.22M | US$116M | +30,574 | Sep 30, 2026 |
| Revolution Medicines, Inc. | 423K | US$86.8M | +12,558 | Sep 30, 2026 |
| Cytokinetics, Incorporated | 517K | US$34.1M | +42,278 | Sep 30, 2026 |
| Disc Medicine, Inc. | 400K | US$26.2M | +160K | Sep 30, 2026 |
| Septerna, Inc. | 64,000 | US$2.5M | new | Sep 30, 2026 |
| Trevi Therapeutics, Inc. | 137K | US$1.96M | +62,000 | Sep 30, 2026 |